Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
29 Dec 2011
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
28 Dec 2011
Changes in UCB’s Executive Committee
Read More
28 Dec 2011
Immunomedics and UCB announce restructuring of epratuzumab license agreement
Read More
22 Dec 2011
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
21 Dec 2011
UCB en Close the Gap slaan handen in elkaar
Read More
21 Dec 2011
UCB collabore avec Close the Gap
Read More
21 Dec 2011
UCB announces start of the EXXELERATE™ clinical study in rheumatoid arthritis
Read More
15 Dec 2011
Acquisition of own shares in the framework of employees’ long-term incentive plans
Read More
5 Dec 2011
Long-term use of antiepileptic drug Vimpat® (lacosamide) reduced seizure frequency and severity and improved health-related quality of life measures
Read More
30 Nov 2011
New data on Vimpat® (lacosamide) to be presented at the 65th Annual Meeting of the American Epilepsy Society
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
64
Page
65
Page
66
Page
67
Current page
68
Page
69
Page
70
Page
71
Page
72
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss